Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
04/2010
04/29/2010US20100103358 Hybrid polymer materials for liquid crystal alignment layers
04/29/2010DE19823940B4 Enterische Fluoxetinpellets Enteric Fluoxetinpellets
04/29/2010CA2740364A1 Tetrahydronaphthalene compounds
04/28/2010EP2180015A1 Polyimides with piezoelectric properties
04/28/2010EP2178880A1 Process for the synthesis of e1 activating enzyme inhibitors
04/28/2010CN1642638B Catalysts and method for the production of amines
04/28/2010CN101698648A Novel multidentate monophenol oxygroup ligand zinc complex and preparation method and application thereof
04/27/2010CA2345118C Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/27/2010CA2338968C Glucocorticoid-selective agents
04/22/2010WO2010043571A1 Process for the preparation of optically active (s)-(-)-2-(n-propylamino)-5-methoxytetraline and (s)-(-)-2-(n-propylamino)-5-hydroxytetraline compounds
04/22/2010WO2010043412A1 Co-crystals of tramadol and nsaids
04/22/2010WO2010043180A1 Ethoxy diphenyl ethane derivates, preparation processes and uses thereof
04/22/2010WO2010042998A1 S1p receptors modulators
04/22/2010US20100099898 Processes and Intermediates For Preparing Benzyle Epoxides
04/22/2010CA2739901A1 S1p receptors modulators
04/22/2010CA2737754A1 Co-crystals of tramadol and nsaids
04/22/2010CA2735101A1 Process for the preparation of optically active (s)-(-)-2-(n-propylamino)-5-methoxytetraline and (s)-(-)-2-(n-propylamino)-5-hydroxytetraline compounds
04/21/2010EP2177215A1 Co-crystals of tramadol and NSAIDs
04/21/2010EP2175854A1 Improved method for the synthesis of substituted formylamines and substituted amines
04/20/2010US7700658 Administering 3-[[3-(4-chloro-3-ethylphenoxy)phenyl][[3-(1,1,2,2- tetrafluoroethoxy)phenyl]-methyl]amino]- 1,1,1-trifluoro-2-propanol(ylgucpd25); anticholesterol agents to increase the level of high density lipoproteins; atherosclerosis; coronary artery; strokes, cardiovasculardiseases; dyslipidemia
04/20/2010CA2388240C Phenoxy carboxylic acid compounds and compositions for delivering active agents
04/20/2010CA2299429C New lipopolyamines,their preparation and the use thereof
04/15/2010WO2010041748A1 Fluorene compound and use thereof for medical purposes
04/14/2010EP2173703A1 Fluoroalkyl surfactants
04/14/2010CN101693667A Perfume fouramine and derivant thereof and preparation method and application thereof
04/14/2010CN101311162B Method for preparing 2,5-dimethoxy phenylethylamine
04/13/2010US7696184 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
04/13/2010US7696129 Substituted aromatic amide derivative, intermediate thereof, agrohorticultural insecticide containing thereof and method for the use thereof
04/08/2010WO2009155488A3 Novel oxalate salt and crystal of o-desmethylvenlafaxine
04/08/2010US20100086915 Detection of esr1 amplification in breast cancer
04/08/2010US20100084257 Method for the continuous separation of mixtures comprising morpholine (mo), monoaminodiglycol (adg), ammonia and water by means of distillation
04/07/2010EP2172444A1 Pet probe having alkoxy group substituted by fluorine and hydroxy group
04/07/2010EP2172443A1 Method for producing optically active amine
04/07/2010EP2170840A1 An improved process for preparing purine derivative
04/07/2010EP1431275B1 Diaryl ether derivative, addition salt thereof, and immunosuppressant
04/07/2010EP1311515B1 Amino acid-derived cyclic phosphonamides and methods of synthesizing the same
04/07/2010CN101691318A N-arylation method taking substituted adipic dihydrazide as ligand in aqueous phase system
04/06/2010CA2513738C Casr antagonist
04/06/2010CA2496712C New process for synthesizing derivatives of 1,3,4,5-tetrahydro-2h-3-benzazepin-2-one and its application to the synthesis of ivabradine and its pharmaceutically acceptable acid addition salts
04/02/2010CA2678345A1 Branched polyamines and formulations thereof for use in medical devices
03/2010
03/31/2010EP2168944A1 Amine compound and pharmaceutical use thereof
03/31/2010EP2167480A2 Cationic lipids compositions and methods for enhancing immune responses to vaccines
03/31/2010CN101687734A A process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates
03/31/2010CN101684075A Metal complex ligand, metal complex, preparation method and application thereof, high molecular polymer, preparation method and application thereof
03/31/2010CN101684074A Unsymmetrical hydrogen transfer synthetic method of (R)-salmeterol
03/30/2010US7687546 Quaternary ammonium compound, process for producing the same, therapeutic agent for cerebrovascular disorder, and therapeutic agent for heart disease
03/25/2010WO2010032254A1 Industrial process for cis(+m-2-r(dimethylamino)-methyl-1-(3- methoxyphenyl) cyclohexanol hydrochloride
03/25/2010WO2010031719A1 Method for the continuous production of an amine using an aluminium-copper catalyst
03/25/2010WO2010007253A3 Novel method for preparing functionalized benzocyclobutenes, and use in the synthesis of ivabradine and of addition salts thereof with a pharmaceutically acceptable acid
03/24/2010CN101679219A Synthetic ion channels
03/24/2010CN101679210A Process of racemisation of optically active alpha aminoacetals
03/24/2010CN101676260A Triphenylamine derivative, a method for manufacturing triphenylamine derivates and electronic photographic photoreceptor
03/24/2010CN100595190C Method for synthesizing (R)-toliprolol
03/23/2010US7682708 Dendrimers
03/18/2010WO2010029950A1 Process for producing optically active epoxy compound and optically active sulfoxide compound, ligand and complex for use in the process, and process for producing the complex
03/17/2010EP2162426A1 Process of racemisation of optically active alpha aminoacetals
03/17/2010EP1031569B1 Salt of a 7-isoindolinequinolonecarboxylic acid derivative, monohydrate thereof and composition containing the same as active ingredient
03/17/2010CN101671265A New benzocyclobutane, preparation method thereof and application thereof
03/17/2010CN101671262A Method for producing ortho-trifluoro-methoxyaniline
03/16/2010US7678941 Polyoxyalkylene ammonium salts and their use as antistatic agents
03/11/2010WO2010026957A1 Water-soluble rotaxane-type fluorescent dye and fluorescent organic molecule
03/11/2010WO2009034432A8 Novel compounds active as muscarinic receptor antagonists
03/10/2010EP1527041B1 Process for the preparation of primary amines
03/10/2010CN101665441A Method for preparing l-betaxolol hydrochloride
03/10/2010CN100593535C Green synthetic process of 2-alkoxyl-5-acetylaminoaniline
03/09/2010US7674938 Selective beta 3-adrenoceptor stimulants; obesity, diabetes mellitus, hyperlipidemia, pollakiuria, urinary incontinence, intestinal hypermotility; e.g. 4'-{2-[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl ethylamino]ethoxy}-2,3',5'-trimethylbiphenyl-4-carboxylic acid
03/09/2010US7674825 Cardiovascular disorders; stimulant of guanylate cyclase
03/04/2010WO2009141170A3 Compounds suited as nanocarriers for active agents and their use
03/04/2010US20100055126 Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
03/03/2010EP2159216A1 Ih - Modulators
03/02/2010US7671225 1-Secondary-phosphino-2-[(2'-secondary-phosphino-C aromat-1'-yl)hydroxymethyl]ferrocenes as ligands for metal complexes; 1-diphenylphosphino-2-[ alpha-hydroxy(o-diphenylphos-phinophenyl),methyl]ferrocene, a ligand for rhodium dinorbornadiene; hydroxy-containing ligand gave higher yields than methoxy
03/02/2010US7671087 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
02/2010
02/25/2010WO2010021351A1 Cycloalkylamine derivative
02/25/2010US20100048893 Substituted arylalkanoic acid derivatives and use thereof
02/24/2010EP2157077A1 Method for producing triarylamine compound
02/24/2010EP2155659A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
02/24/2010EP2154962A1 Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
02/18/2010CA2734322A1 Na channels, disease, and related assays and compositions
02/17/2010CN101648882A Production method of 4-[(R,S)-1-amino-(2',4'-dimethoxylphenyl)] phenoxyacetic acid
02/17/2010CN100590114C Method for synthesizing (S)-toliprolol
02/16/2010CA2452918C New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias
02/11/2010WO2010017563A1 Polymeric ionic liquids, methods of making and methods of use thereof
02/11/2010WO2010017550A2 Lipid compounds for supression of tumorigenesis
02/11/2010US20100035999 Additives and products includings oligoesters
02/11/2010CA2733458A1 Lipid compounds for suppression of tumorigenesis
02/10/2010EP2151236A1 G-protein-conjugated receptor agonist
02/10/2010CN101643429A Method for preparing 3,3'-dichlorobenzidine hydrochloride through formaldehyde-hydrazine hydrate reduction
02/10/2010CN101643428A Method for preparing 3,3'-dimethoxybenzidine hydrochloride
02/09/2010US7659415 Dianionic chelating ligands with a bridged-bis-bi-aryl structure; For catalytic polymerization of ethylene/olefin copolymers
02/04/2010WO2010013809A1 Optically active titanium-salan compounds and process for production thereof
02/04/2010WO2010012471A1 Salts of tramadol and ibuprofen and their crystal form in the treatment of pain
02/04/2010US20100029639 Ion channel modulating compounds and uses thereof
02/03/2010EP2149546A1 Salts of tramadol and ibuprofen and their crystal form in the treatment of pain
02/03/2010CN101641323A Diamine compound, polyamic acid, polyimide and liquid crystal aligning agent
02/03/2010CN101641322A Diamine compound, polyamic acid, polyimide and liquid crystal aligning agent
02/02/2010US7655653 Tetrahydrobenzfluorene derivatives
02/02/2010CA2494176C Intermediates in producing phenoxyacetic acid derivatives and method of using the same
01/2010
01/28/2010WO2010010412A2 Method for the preparation of n-methyl-aryloxy-propanamine derivatives
01/28/2010WO2010009508A1 Antiparasitic compounds
01/28/2010US20100022657 Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 140